Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 42,000 shares at $25.45 ($1.0M) on 2022-09-13, disclosed to the SEC on 2022-09-15.
Open-market sale of $1.0M RLAY by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.45 | 14,000 | $356K | 35.0% |
| 2 | $23.47 | 14,000 | $329K | 32.3% |
| 3 | $23.80 | 14,000 | $333K | 32.7% |
| Total | $24.24 avg | 42,000 | $1.0M | 100% |
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-07-08 | $944K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |